Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDARUCIZUMAB for Haemorrhage: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 83 adverse event reports in the FDA FAERS database where IDARUCIZUMAB was used for Haemorrhage.

Most Reported Side Effects for IDARUCIZUMAB

Side Effect Reports % Deaths Hosp.
Death 170 10.9% 170 26
Haemorrhage 110 7.0% 67 45
Cerebral haemorrhage 92 5.9% 72 44
Gastrointestinal haemorrhage 83 5.3% 68 39
Haemorrhage intracranial 68 4.4% 51 35
Multiple organ dysfunction syndrome 68 4.4% 68 22
Drug ineffective 58 3.7% 20 29
Pneumonia 51 3.3% 32 23
Acute kidney injury 49 3.1% 28 19
Cerebral infarction 46 2.9% 24 19
Sepsis 46 2.9% 38 20
Shock haemorrhagic 43 2.8% 40 14
Ischaemic stroke 40 2.6% 15 19
Cardiac failure 35 2.2% 29 8
Septic shock 34 2.2% 32 15

Other Indications for IDARUCIZUMAB

Procoagulant therapy (1,040) Product used for unknown indication (165) Gastrointestinal haemorrhage (42) Haemorrhage intracranial (29) Surgery (29) Cerebral haemorrhage (21) Cerebrovascular accident (12) Ischaemic stroke (12) Upper gastrointestinal haemorrhage (10) Atrial fibrillation (9)

Other Drugs Used for Haemorrhage

ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (751) COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTEIN C\PROTEIN S HUMAN\PROTHROMBIN (318) COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL (273) TRANEXAMIC ACID (247) EFMOROCTOCOG ALFA (219) ANTI-INHIBITOR COAGULANT COMPLEX (116) EFTRENONACOG ALFA (109) COAGULATION FACTOR VIIA RECOMBINANT HUMAN (92) ANDEXANET ALFA (85) COAGULATION FACTOR IX RECOMBINANT HUMAN (65)

Related Pages

IDARUCIZUMAB Full Profile All Haemorrhage Drugs IDARUCIZUMAB Demographics IDARUCIZUMAB Timeline